BCHN 📈 Burckhardt Compression - Overview
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0025536027
BCHN: Reciprocating Compressors, Compressor Systems, Diaphragm Compressors
Burckhardt Compression Holding AG manufactures and sells reciprocating compressors worldwide. The company offers Laby, a labyrinth piston compressor that compresses bone-dry, dirty, abrasive, and other gases; Laby-GI compressors for offshore vessels and installations; process gas compressors API 618 for high-pressure compression of hydrogen, hydrocarbon, and corrosive gasses; hyper compressor, a high-pressure reciprocating compressor for low-density polyethylene and ethylene-vinyl acetate plants; and standard high pressure compressors that compress air, hydrogen, nitrogen, helium, argon, natural gas, and other non-corrosive gases and gas mixtures. It also provides high-speed compressors, which are used for natural gas processing and transport applications; compressor systems and packages; and diaphragm compressors that are used for hydrogen fueling and trailer filling stations, as well as for the compression of small quantities of pure gas for medical and other purposes, as well as marine high-pressure compressors, which are used to handle relatively low boil-off gases rates. In addition, it provides various compressor components, such as compressor valves, rings and packings, capital parts, labyrinth piston compressor components, and hyper/secondary compressor components. Further, it provides services comprising valve, spare parts logistic, revamp and upgrade, component repair, field, condition monitoring and diagnostic, technical support, and training services. The company offers compressor systems used in the petrochemical, chemical, gas transport and storage, hydrogen mobility and energy, industrial gas, refinery and gas, gathering, and processing sectors. The company was founded in 1844 and is headquartered in Winterthur, Switzerland. Web URL: https://www.burckhardtcompression.com
Additional Sources for BCHN Stock
BCHN Stock Overview
Market Cap in USD | 2,513m |
Sector | Industrials |
Industry | Specialty Industrial Machinery |
GiC Sub-Industry | Industrial Machinery & Supplies & Components |
IPO / Inception |
BCHN Stock Ratings
Growth 5y | 92.5% |
Fundamental | 60.4% |
Dividend | 68.0% |
Rel. Strength Industry | 54.5 |
Analysts | - |
Fair Price Momentum | 725.37 CHF |
Fair Price DCF | 798.01 CHF |
BCHN Dividends
Dividend Yield 12m | 2.41% |
Yield on Cost 5y | 6.59% |
Annual Growth 5y | 14.87% |
Payout Consistency | 94.3% |
BCHN Growth Ratios
Growth Correlation 3m | 82.9% |
Growth Correlation 12m | 87.3% |
Growth Correlation 5y | 94.8% |
CAGR 5y | 21.99% |
CAGR/Mean DD 5y | 2.10 |
Sharpe Ratio 12m | 1.03 |
Alpha | 8.46 |
Beta | 0.73 |
Volatility | 25.59% |
Current Volume | 7.1k |
Average Volume 20d | 5.8k |
What is the price of BCHN stocks?
As of December 22, 2024, the stock is trading at CHF 639.00 with a total of 7,137 shares traded.
Over the past week, the price has changed by -3.17%, over one month by +0.00%, over three months by +8.26% and over the past year by +27.68%.
As of December 22, 2024, the stock is trading at CHF 639.00 with a total of 7,137 shares traded.
Over the past week, the price has changed by -3.17%, over one month by +0.00%, over three months by +8.26% and over the past year by +27.68%.
Is Burckhardt Compression a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Burckhardt Compression (SW:BCHN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 60.41 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCHN as of December 2024 is 725.37. This means that BCHN is currently undervalued and has a potential upside of +13.52% (Margin of Safety).
Yes, based on ValueRay Fundamental Analyses, Burckhardt Compression (SW:BCHN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 60.41 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCHN as of December 2024 is 725.37. This means that BCHN is currently undervalued and has a potential upside of +13.52% (Margin of Safety).
Is BCHN a buy, sell or hold?
Burckhardt Compression has no consensus analysts rating.
Burckhardt Compression has no consensus analysts rating.
What are the forecast for BCHN stock price target?
According to ValueRays Forecast Model, BCHN Burckhardt Compression will be worth about 796.2 in December 2025. The stock is currently trading at 639.00. This means that the stock has a potential upside of +24.59%.
According to ValueRays Forecast Model, BCHN Burckhardt Compression will be worth about 796.2 in December 2025. The stock is currently trading at 639.00. This means that the stock has a potential upside of +24.59%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 699.1 | 9.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 796.2 | 24.6% |